TMAM
IONS icon

Tokio Marine Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Tokio Marine Asset Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-17,100
Closed -$967K – 391
2020
Q4 		$967K Buy
17,100
+2,000
+13% +$99.7K 0.11% 109
2020
Q3 		$716K Buy
+15,100
New +$839K 0.09% 119

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Tokio Marine Asset Management's IONS Position: Q1 2021 in Review

Tokio Marine Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q1 2021, closing a stake of 17,100 shares — an estimated $967K sold.

Tokio Marine Asset Management first reported a position in IONS in Q3 2020 and held it in 2 quarters. The position peaked at $967K in Q4 2020. 364 funds tracked by Wall St. Rank hold IONS as of Q1 2021.

  • Tokio Marine Asset Management reported no remaining Ionis Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Tokio Marine Asset Management sold 17,100 Ionis Pharmaceuticals shares in Q1 2021, an estimated $967K.
  • Tokio Marine Asset Management first reported a position in Ionis Pharmaceuticals in Q3 2020 and held it in 2 quarters.
  • Tokio Marine Asset Management's Ionis Pharmaceuticals position peaked at $967K in Q4 2020.
  • 364 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2021.

Based on Tokio Marine Asset Management's 13F filing for Q1 2021, filed 17 May 2021.